Skip to content

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

Local Tranexamic Acid During Vaginal Hysterectomy to Reduce Blood Loss

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04760301
Enrollment
60
Registered
2021-02-18
Start date
2021-02-16
Completion date
2026-06-30
Last updated
2025-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Loss

Brief summary

Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation

Detailed description

This randomized control trial will investigate whether local tranexamic acid is efficient for decreasing bleeding during vaginal hysterectomy. The investigators will randomize local placebo (saline) vs. local 1 gr tranexamic acid; local 1gr tranexamic acid diluted in 10 ml saline and local 10 ml saline at the beginning of surgery.

Interventions

DRUGlocal tranexamic acid injection

local tranexamic acid injection to cervix- 1 g tranexamic acid diluted in 10 ml saline

OTHERlocal normal saline injection to cervix

local normal saline injection to the cervix- 20 ml saline

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* 20-90 years old female patients going through vaginal hysterctomy

Exclusion criteria

* massive bleeding during operation due to major vessles injury * known coagulopathies * sensitivity to tranexamic acid * medical need in tranexamic acid administration during operation due to bleeding

Design outcomes

Primary

MeasureTime frameDescription
Blood loss during operation - measure in mlEnd of surgeryAt the end of the surgery, surgeon will measure the blood in the suction can

Countries

Israel

Contacts

Primary ContactYair Daykan, M.D
yair.dykan@gmail.com0542198231
Backup ContactGal Cohen, M.D
galcwork@gmail.com0545915788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026